Answers are grounded in this paper and cite their sources.
Experimental study demonstrates telomeric G-quadruplex stabilization and POT1 uncapping in human cancer cells, highlighting a targeted mechanism to trigger telomeric DNA-damage responses.
We describe a novel synthetic small molecule which shows an unprecedented stabilization of the human telomeric G-quadruplex with high selectivity relative to double-stranded DNA. We report that this compound can be used in vitro to inhibit telomerase activity and to uncap human POT1 (protection of telomeres 1) from the telomeric G-overhang. We also show that the small molecule G-quadruplex binder induces a partial alteration of shelterin through POT1 uncapping from telomeres in human HT1080 cancer cells and the presence of gammaH2AX foci colocalized at telomeres.
No takes yet. Share an insight, caveat, or question.
Rodriguez et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: